The medical device user manual provides information on the Abbott Insertable Cardiac Monitor (ICM), specifically highlighting its ability to detect atrial fibrillation (AFib).
Atrial Fibrillation Statistics
AFib is particularly relevant to stroke patients, with patients with AFib being 5x more likely to have a stroke.
Long-term Monitoring with an Insertable Cardiac Monitor (ICM)
The ICM detects AFib 3x faster than external cardiac monitoring methods, making it an effective tool for detecting AFib in patients with cryptogenic stroke (unexplained stroke).
ASSERT Study
A nationwide study of U.S. Medicare beneficiaries with cryptogenic stroke found that ICMs provide effective AFib detection, with almost three times more AFib detected compared to external cardiac monitors (ECMs).
The study also found that longer monitoring duration leads to higher AFib diagnosis rates and that ICMs provide faster AFib diagnosis, with a median time to AFib detection of 84 days.
Manual:
Download: DETECTING ATRIAL FIBRILLATION WITH ASSERT-IQ INSERTABLE CARDIAC MONITOR (ICM)
Chat: Powered By VoiceSphere